Growth is largely anchored in the hospital sector, which remains the dominant end-user due to high patient volumes and the continuous requirement for sterile, disposable, and surgical supplies. Diagnostic tools are currently experiencing the most rapid adoption, fueled by an increasing global emphasis on preventive care and routine health screenings. Regionally, North America maintains its lead with a 40.75% market share, supported by robust healthcare infrastructure and high spending levels. However, the Asia Pacific region is rapidly gaining momentum, expected to register the highest growth rate of 10.2% during the forecast period.

Investment trends reflect a strategic shift as capital flows toward recurring-revenue models and home-based care. Major industry players are aggressively pursuing consolidation to secure footholds in specialized channels, as evidenced by significant acquisitions like Cardinal Health’s $1.1 billion purchase of the Advanced Diabetes Supply Group. Despite this activity, the market remains notably fragmented, with the top five companies controlling only 15.72% of the sector. This landscape suggests that the coming years will likely be defined by further M&A activity as firms compete to dominate high-growth segments like diabetes care and home medical equipment.